Topical 2% Povidone-Iodine Gel in Verruca Vulgaris
Launched by VELOCE BIOPHARMA LLC · Jan 31, 2020
Trial Information
Current as of May 18, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject is able to comprehend and is willing to sign an informed consent/assent for participation in this study.
- • Male or female ≥ 8 years old.
- • Subject has a clinical diagnosis of verruca vulgaris (common warts).
- • Subject has up to 6 warts located on the trunk or extremities
- Exclusion Criteria:
- • Subject has clinically atypical warts on the trunk or extremities.
- • Subject is immunocompromised (e.g., due to chemotherapy, systemic steroids, genetic immunodeficiency, transplant status, etc.)
- • Subject has periungual, subungual, genital, anal, mosaic, plantar, flat, or filiform wart identified as a wart for study treatment.
About Veloce Biopharma Llc
Veloce Biopharma LLC is a clinical-stage biotechnology company dedicated to advancing innovative therapeutic solutions for unmet medical needs. With a focus on developing novel biopharmaceuticals, Veloce Biopharma leverages cutting-edge research and technology to enhance patient outcomes across various disease indications. Committed to rigorous scientific standards and ethical practices, the company collaborates with leading researchers and institutions to accelerate drug development and bring transformative therapies to market. Through its dedication to excellence, Veloce Biopharma aims to make a meaningful impact on global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hunt Valley, Maryland, United States
Plymouth Meeting, Pennsylvania, United States
Sugarloaf, Pennsylvania, United States
Upper Saint Clair, Pennsylvania, United States
Fort Mill, South Carolina, United States
Arlington, Virginia, United States
Lynchburg, Virginia, United States
Patients applied
Trial Officials
Samuel Barone, MD
Study Director
Veloce BioPharma LLC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials